These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19095606)

  • 21. Twelve shifting paradigms in diabetic renal disease and hypertension.
    Mogensen CE
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diabetes, hypertension, and cardiovascular disease: an update.
    Sowers JR; Epstein M; Frohlich ED
    Hypertension; 2001 Apr; 37(4):1053-9. PubMed ID: 11304502
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Microalbuminuria in essential hypertension.
    Crippa G
    J Hum Hypertens; 2002 Mar; 16 Suppl 1():S74-7. PubMed ID: 11986900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug treatment for hypertensive patients in special situations: diabetes and hypertension.
    Mogensen CE
    Clin Exp Hypertens; 1999; 21(5-6):895-906. PubMed ID: 10423111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Microalbuminuria in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study.
    Wachtell K; Olsen MH; Dahlöf B; Devereux RB; Kjeldsen SE; Nieminen MS; Okin PM; Papademetriou V; Mogensen CE; Borch-Johnsen K; Ibsen H
    J Hypertens; 2002 Mar; 20(3):405-12. PubMed ID: 11875307
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microalbuminuria and essential hypertension: renal and cardiovascular implications.
    Luft FC
    Curr Opin Nephrol Hypertens; 1997 Nov; 6(6):553-7. PubMed ID: 9375269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A structured review of the relationship between microalbuminuria and cardiovascular events in patients with diabetes mellitus and hypertension.
    Park HY; Schumock GT; Pickard AS; Akhras K
    Pharmacotherapy; 2003 Dec; 23(12):1611-6. PubMed ID: 14695040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships among microalbuminuria, insulin resistance and renal-cardiac complications in insulin dependent and non insulin dependent diabetes.
    Nosadini R; Brocco E
    Exp Clin Endocrinol Diabetes; 1997; 105 Suppl 2():1-7. PubMed ID: 9288531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroAlbuminuria Prevalence Study (MAPS) in hypertensive type 2 diabetic patients in Hong Kong.
    Yeung VT; Lee KF; Chan SH; Ho LF; Leung SK; Wong HY;
    Hong Kong Med J; 2006 Jun; 12(3):185-90. PubMed ID: 16760545
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microalbuminuria screening by reagent strip predicts cardiovascular risk in hypertension.
    Agrawal B; Berger A; Wolf K; Luft FC
    J Hypertens; 1996 Feb; 14(2):223-8. PubMed ID: 8728300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does microalbuminuria predict cardiovascular events in nondiabetic men with treated hypertension? Risk Factor Intervention Study Group.
    Agewall S; Wikstrand J; Ljungman S; Herlitz H; Fagerberg B
    Am J Hypertens; 1995 Apr; 8(4 Pt 1):337-42. PubMed ID: 7619345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usefulness of microalbuminuria in predicting cardiovascular mortality in treated hypertensive men with and without diabetes mellitus. Risk Factor Intervention Study Group.
    Agewall S; Wikstrand J; Ljungman S; Fagerberg B
    Am J Cardiol; 1997 Jul; 80(2):164-9. PubMed ID: 9230153
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study.
    Wang W; Lee ET; Fabsitz RR; Devereux R; Best L; Welty TK; Howard BV
    Hypertension; 2006 Mar; 47(3):403-9. PubMed ID: 16432042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of microalbuminuria on left ventricular geometry and function in hypertensive patients with type 2 diabetes mellitus.
    Picca M; Agozzino F; Pelosi G
    Ital Heart J; 2003 Jan; 4(1):48-52. PubMed ID: 12690921
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic aspects of development of microalbuminuria in patients with hypertensive disease].
    Minushkina LO; Brazhnik VA; Nosikov VV; Zateĭshchikov DA
    Kardiologiia; 2008; 48(11):29-35. PubMed ID: 19076077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes, hypertension, and cardiovascular derangements: pathophysiology and management.
    El-Atat F; McFarlane SI; Sowers JR
    Curr Hypertens Rep; 2004 Jun; 6(3):215-23. PubMed ID: 15128475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Approaches to prevention of cardiovascular complications and events in diabetes mellitus.
    Coccheri S
    Drugs; 2007; 67(7):997-1026. PubMed ID: 17488145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of angiotensin II type 1 receptor antagonists in elderly patients with hypertension.
    Thomas GN; Chan P; Tomlinson B
    Drugs Aging; 2006; 23(2):131-55. PubMed ID: 16536636
    [TBL] [Abstract][Full Text] [Related]  

  • 39. What is the evidence that microalbuminuria is a predictor of cardiovascular disease events?
    Yuyun MF; Adler AI; Wareham NJ
    Curr Opin Nephrol Hypertens; 2005 May; 14(3):271-6. PubMed ID: 15821422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Microalbuminuria in nondiabetic adults].
    Cirillo M; De Santo NG
    G Ital Nefrol; 2002; 19(3):273-7. PubMed ID: 12195394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.